Sales 2024 * | 28.87M 21.04M | Sales 2025 * | 29.33M 21.37M | Capitalization | 207M 151M |
---|---|---|---|---|---|
Net income 2024 * | 12M 8.74M | Net income 2025 * | 13M 9.47M | EV / Sales 2024 * | 7.17 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 7.05 x |
P/E ratio 2024 * |
17.5
x | P/E ratio 2025 * |
19.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.49% |
Latest transcript on Cipher Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 19-03-25 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 22-08-14 |
James Bowen
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 16-08-07 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 23-06-20 |
Craig Mull
CEO | Chief Executive Officer | - | 19-03-25 |
1st Jan change | Capi. | |
---|---|---|
+33.25% | 699B | |
+25.93% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.92% | 236B | |
+4.89% | 198B | |
-10.18% | 194B | |
-3.69% | 149B |